Selvita S.A. (WSE:SLV)
37.00
-1.30 (-3.39%)
Oct 3, 2025, 5:04 PM CET
Selvita Revenue
Selvita had revenue of 95.03M PLN in the quarter ending June 30, 2025, with 17.44% growth. This brings the company's revenue in the last twelve months to 373.90M, up 13.64% year-over-year. In the year 2024, Selvita had annual revenue of 345.76M, down -1.73%.
Revenue (ttm)
373.90M
Revenue Growth
+13.64%
P/S Ratio
1.82
Revenue / Employee
385.86K
Employees
969
Market Cap
679.15M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 345.76M | -6.09M | -1.73% |
Dec 31, 2023 | 351.85M | -12.70M | -3.48% |
Dec 31, 2022 | 364.55M | 48.83M | 15.47% |
Dec 31, 2021 | 315.73M | 173.80M | 122.46% |
Dec 31, 2020 | 141.93M | 88.32M | 164.78% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Diagnostyka | 2.17B |
NEUCA | 13.04B |
Synektik Spólka Akcyjna | 623.20M |
Voxel | 560.38M |
Celon Pharma | 206.22M |
Centrum Medyczne ENEL-MED | 789.78M |
Ryvu Therapeutics | 130.10M |
Scope Fluidics | 720.00K |